Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore
Prenetics Global Limited (NASDAQ: PRE), a consumer health sciences company, announced CEO Danny Yeung will deliver a keynote at Token 2049 in Singapore on October 2, 2025. The presentation will focus on IM8, their supplement brand, and their Bitcoin treasury strategy.
The company currently holds 248.42 BTC at an average price of $108,600 per BTC, with a strategy to acquire 1 Bitcoin daily. Their supplement brand IM8 is projected to achieve $100 million in annual recurring revenue within its first year. Prenetics maintains a strong financial position with $63.5 million in current assets, including $46.3 million from ACT Genomics divestment, $17.2 million in cash, and other assets.
Prenetics Global Limited (NASDAQ: PRE), azienda nell’ambito delle scienze della salute per i consumatori, ha comunicato che il CEO Danny Yeung terrà un intervento da keynote a Token 2049 a Singapore il 2 ottobre 2025. L’esposizione verterà su IM8, il loro marchio di integratori, e sulla strategia di tesoreria in Bitcoin.
L’azienda possiede attualmente 248,42 BTC con un prezzo medio di $108.600 per BTC, adottando una strategia di acquisto di 1 Bitcoin al giorno. Il marchio di integratori IM8 è previsto possa generare $100 milioni di entrate ricorrenti annue nel primo anno. Prenetics mantiene una solida posizione finanziaria con $63,5 milioni in attività correnti, includendo $46,3 milioni provenienti dalla cessione di ACT Genomics, $17,2 milioni in contanti e altre attività.
Prenetics Global Limited (NASDAQ: PRE), una empresa de ciencias de la salud para consumo, anunció que su CEO Danny Yeung dará una ponencia en Token 2049 en Singapur el 2 de octubre de 2025. La presentación se centrará en IM8, su marca de suplementos, y en su estrategia de tesorería en Bitcoin.
La compañía posee actualmente 248,42 BTC a un precio medio de $108.600 por BTC, con una estrategia de adquirir 1 Bitcoin diario. Se espera que su marca de suplementos IM8 alcance $100 millones en ingresos anuales recurrentes en su primer año. Prenetics mantiene una sólida posición financiera con $63,5 millones en activos corrientes, incluyendo $46,3 millones procedentes de la venta de ACT Genomics, $17,2 millones en efectivo y otros activos.
Prenetics Global Limited (NASDAQ: PRE)은 소비자 건강 과학 분야의 기업으로, CEO Danny Yeung가 2025년 10월 2일 싱가포르에서 열리는 Token 2049에서 기조연설을 할 것이라고 발표했습니다. 발표는 IM8(보충제 브랜드)과 비트코인 보유 전략에 초점을 맞출 예정입니다.
현재 회사는 248.42 BTC를 보유하고 있으며 BTC당 평균가가 $108,600로 매일 1비트코인씩 매수하는 전략을 구사하고 있습니다. IM8 브랜드는 첫 해에 연간 재발생 매출 1억 달러를 달성할 것으로 예상됩니다. Prenetics는 ACT Genomics 매각으로 얻은 4630만 달러를 포함해 현금 1720만 달러, 기타 자산을 포함한 현재 자산 6350만 달러의 견고한 재무 상태를 유지하고 있습니다.
Prenetics Global Limited (NASDAQ: PRE), société spécialisée dans les sciences de la santé consommateur, a annoncé que le PDG Danny Yeung prononcera un discours principal lors du Token 2049 à Singapour le 2 octobre 2025. La présentation portera sur IM8, leur marque de compléments et sur leur stratégie de trésorerie en Bitcoin.
L’entreprise détient actuellement 248,42 BTC à un prix moyen de $108 600 par BTC, avec une stratégie d’achat de 1 Bitcoin par jour. Leur marque de compléments IM8 devrait atteindre 100 millions de dollars de revenus annuels récurrents au cours de sa première année. Prenetics maintient une solide position financière avec $63,5 millions d’actifs courants, dont 46,3 millions de dollars provenant de la cession d’ACT Genomics, 17,2 millions en liquidités et d’autres actifs.
Prenetics Global Limited (NASDAQ: PRE), ein Unternehmen im Bereich der Consumer Health Sciences, gab bekannt, dass CEO Danny Yeung am Token 2049 in Singapur am 2. Oktober 2025 eine Hauptrede halten wird. Die Präsentation konzentriert sich auf IM8, ihre Marke für Nahrungsergänzungsmittel, und ihre Bitcoin-Tresor-Strategie.
Das Unternehmen hält derzeit 248,42 BTC zu einem Durchschnittspreis von $108.600 pro BTC und verfolgt die Strategie, täglich 1 Bitcoin zu erwerben. Die IM8-Marke soll im ersten Jahr 100 Millionen USD an wiederkehrenden Einnahmen erzielen. Prenetics weist eine starke finanzielle Position mit $63,5 Millionen an aktuellen Vermögenswerten aus, darunter 46,3 Millionen USD aus dem ACT Genomics-Verkauf, 17,2 Millionen USD Bargeld und andere Vermögenswerte.
Prenetics Global Limited (NASDAQ: PRE)، شركة علوم صحة للمستهلكين، أعلنت أن المدير التنفيذي دانِي يينغ سيُلقي كلمة رئيسية في Token 2049 في سنغافورة في 2 أكتوبر 2025. ستركز الشريحة على IM8، علامتهم التجارية للمكملات، وعلى استراتيجيتهم لخزانة البيتكوين.
تمتلك الشركة حالياً 248.42 BTC بسعر وسط قدره $108,600 لكل BTC، مع استراتيجية لاقتناء 1 بيتكوين يومياً. من المتوقع أن تحقق علامة IM8 للمكملات 100 مليون دولار من الإيرادات السنوية المتكررة خلال عامها الأول. تحافظ Prenetics على وضع مالي قوي بوجود $63.5 مليوناً من الأصول الجارية، بما في ذلك 46.3 مليون دولار من بيع ACT Genomics، و1.72 مليون دولار كنقد، وأصول أخرى.
Prenetics Global Limited (NASDAQ: PRE)，一家消费健康科学公司，宣布首席执行官 Danny Yeung 将于 2025 年 10 月 2 日在新加坡举行的 Token 2049 上发表主题演讲。演讲将聚焦于他们的补充剂品牌 IM8 及其比特币库藏策略。
公司目前持有 248.42 BTC，其平均价格为每 BTC $108,600，并采用每日购买 1 枚比特币的策略。IM8 补充剂品牌预计在首年实现 $1 亿美元的年经常性收入。Prenetics 拥有稳健的财务状况，当前资产为 $6,350 万美元的资产，其中包括来自 ACT Genomics 出售所得的 4630 万美元、现金 1720 万美元及其他资产。
- IM8 supplement brand projected to reach $100M annual recurring revenue in under 12 months
- Strong balance sheet with $63.5M in current assets
- Strategic Bitcoin holdings of 248.42 BTC with systematic daily acquisition plan
- Successful execution of Bitcoin treasury strategy with average purchase price of $108,600 per BTC
- Significant exposure to volatile cryptocurrency assets through Bitcoin treasury strategy
- Large capital allocation to Bitcoin could impact operational flexibility
Insights
Prenetics is aggressively building a Bitcoin treasury alongside its high-growth IM8 supplement business, creating a unique dual growth strategy.
Prenetics' Bitcoin treasury strategy represents an unusual corporate approach to balance sheet management that merits investor attention. The company has acquired 248.42 BTC at an average price of
What makes this approach noteworthy is the structured, programmatic accumulation method - consistently purchasing 1 Bitcoin daily since August 2025, with plans to continue through year-end and potentially accelerate in 2026. This disciplined dollar-cost averaging reduces timing risk while demonstrating long-term conviction.
Most fascinating is how this treasury strategy is reportedly fueled by their IM8 supplement brand, which they claim is approaching
The company's parallel strategy of operating a high-growth consumer health business while systematically converting cash to Bitcoin creates an unusual investment profile. While most companies with Bitcoin treasury strategies are pure-play crypto firms or have minimal operating businesses, Prenetics is attempting to create value on both fronts - through operational growth and digital asset appreciation.
- Keynote: “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury
- Prenetics currently holds 246 BTC with a NAV of
- Prenetics has
CHARLOTTE, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a leading consumer health sciences company, today announced Chief Executive Officer, Danny Yeung will deliver a keynote address at Token 2049, one of the world’s premier crypto and blockchain conferences, taking place in Singapore.
Danny is scheduled to present on Thursday, October 2, 2025, joining an influential lineup of global thought leaders, innovators, and investors. His keynote, “IM8: The World’s Fastest-Growing Supplement Brand Powering Our Bitcoin Treasury,” will emphasize Prenetics’ unique position as one of the only fast-growing operating companies to also build a sizable digital asset treasury. While most DAT strategies are pursued by firms without a core operating business, Prenetics stands apart due to IM8’s explosive growth to systematically acquire 1 Bitcoin on a daily basis to continually strengthen its balance sheet.
The presentation will also highlight IM8’s extraordinary momentum—on track to surpass
Bitcoin Treasury Strategy Initiative:
Earlier this year, in June 2025, Prenetics announced the adoption of a corporate Bitcoin strategy. The strategy includes allocating a large majority of the Company’s balance sheet to Bitcoin and integrating Bitcoin across its operations.
The program began with an initial purchase of 187.42 BTC for approximately USD
Looking ahead, Prenetics plans to continue its daily acquisition of one Bitcoin through the end of 2025, with expectations to increase the accumulation rate in 2026 as operating cash generation continues to strengthen. Real-time access to the Company’s Bitcoin holdings can be found here.
1Represents current assets, including estimated proceeds from the divestment of ACT Genomics in the form of
About Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a fast growing health and wellness brand, Europa, one of the largest sports distribution companies in the USA and CircleDNA, a leading direct to consumer DNA test. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit prenetics.com.
About Token 2049
Token 2049 is the premier crypto event, organized annually in Singapore, that brings together the world’s leading founders, executives, investors, developers, and media to discuss global developments and trends in the digital asset industry.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com
FAQ
What is Prenetics' (PRE) current Bitcoin holdings and acquisition strategy?
How much revenue is Prenetics' IM8 supplement brand expected to generate?
What is Prenetics' current cash position as of June 2025?
When and where will Prenetics CEO Danny Yeung present at Token 2049?
What is unique about Prenetics' Bitcoin treasury strategy?
